|
|
市场分析报告
|
Motavizumab (CAS 677010-34-3) Market Research Report 2025 BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS).
Global Market Report of Motavizumab (CAS 677010-34-3) December 2024
CAS 677010-34-3 Motavizumab Chemical Report & Database ... listed. The substance covered (Motavizumab) are classified by the Chemical ... Report & Database definitions: Name: Motavizumab: Motavizumab; Numax Synonyms: Numax Chemical ... : Chemical or Reaction Intermediate The Motavizumab Report & Database gives Market ...
Global Respiratory Syncytial Virus Therapeutics Market Size Study, by Drug Type (Palivizumab, Ribavirin, Motavizumab, Other Drug Types), by Route of Administration (Oral, Injectable, Intranasal, Other Route of Administrations), by Patient Type (Adult, Pediatrics), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies) and Regional Forecasts 2022-2032 ... below: By Drug Type: • Palivizumab • Ribavirin • Motavizumab • Other drug types By Route of Administration ...
Prescription Drugs: Market Research Report This report analyzes the worldwide markets for Prescription Drugs in US$ Billion by the following therapeutic class – Oncologics/ Cancer Drugs, Lipid Regulators, Respiratory Agents, Proton Pump Inhibitors, Antidiabetics, Antipsychotics, Antidepressants, ...
The AstraZeneca Intelligence Dossier ... Symbicort Seroquel XR Onglyza Crestor Vimovo Motavizumab TC-5619 Brilinta Cangrelor CM3
|
|
|
|